secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexeo Therapeutics, Inc. (LXEO)
CIK:        0001907108
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001193125-23-272430
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexeo Therapeutics amends charter and bylaws upon IPO closing on Nov 7, 2023
----------------------------------------------------------------------------

- Filed amended certificate of incorporation effective Nov 7, 2023 upon IPO closing.
- Adopted amended and restated bylaws effective Nov 7, 2023.
- Board and stockholders approved both governing documents before IPO closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1907108/000119312523272430/0001193125-23-272430-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1907108/000119312523272430/d576843d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-272430

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer